Literature DB >> 8335182

Nicotinamide--biological actions and therapeutic potential in diabetes prevention. IDIG Workshop, Copenhagen, Denmark, 4-5 December 1992.

F Pociot1, J I Reimers, H U Andersen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8335182     DOI: 10.1007/bf02743277

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  6 in total

Review 1.  Cytokine and free radicals as effector molecules in the destruction of pancreatic beta cells.

Authors:  T Mandrup-Poulsen; S Helqvist; L D Wogensen; J Mølvig; F Pociot; J Johannesen; J Nerup
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

2.  Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo.

Authors:  P W Rankin; E L Jacobson; R C Benjamin; J Moss; M K Jacobson
Journal:  J Biol Chem       Date:  1989-03-15       Impact factor: 5.157

3.  Studies on the ability of compounds to block the diabetogenic activity of streptozotocin.

Authors:  W E Dulin; B M Wyse
Journal:  Diabetes       Date:  1969-07       Impact factor: 9.461

4.  Amelioration of diabetes mellitus in partially depancreatized rats by poly(ADP-ribose) synthetase inhibitors. Evidence of islet B-cell regeneration.

Authors:  Y Yonemura; T Takashima; K Miwa; I Miyazaki; H Yamamoto; H Okamoto
Journal:  Diabetes       Date:  1984-04       Impact factor: 9.461

5.  Tissue culture of human fetal pancreas. Effects of nicotinamide on insulin production and formation of isletlike cell clusters.

Authors:  S Sandler; A Andersson; O Korsgren; J Tollemar; B Petersson; C G Groth; C Hellerström
Journal:  Diabetes       Date:  1989-01       Impact factor: 9.461

6.  Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis. An observation in nonobese diabetic (NOD) mice.

Authors:  K Yamada; K Nonaka; T Hanafusa; A Miyazaki; H Toyoshima; S Tarui
Journal:  Diabetes       Date:  1982-09       Impact factor: 9.461

  6 in total
  11 in total

1.  Metabolic signatures of exercise in human plasma.

Authors:  Gregory D Lewis; Laurie Farrell; Malissa J Wood; Maryann Martinovic; Zoltan Arany; Glenn C Rowe; Amanda Souza; Susan Cheng; Elizabeth L McCabe; Elaine Yang; Xu Shi; Rahul Deo; Frederick P Roth; Aarti Asnani; Eugene P Rhee; David M Systrom; Marc J Semigran; Ramachandran S Vasan; Steven A Carr; Thomas J Wang; Marc S Sabatine; Clary B Clish; Robert E Gerszten
Journal:  Sci Transl Med       Date:  2010-05-26       Impact factor: 17.956

2.  Hypoglycemic Effects of sesquiterpene lactones from Byrsonima crassifolia.

Authors:  Rosa Martha Pérez Gutiérrez; Alethia Muñiz Ramirez
Journal:  Food Sci Biotechnol       Date:  2016-08-31       Impact factor: 2.391

3.  Intervening before the onset of Type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT).

Authors: 
Journal:  Diabetologia       Date:  2003-02-27       Impact factor: 10.122

4.  Activation of a novel non-selective cation channel by alloxan and H2O2 in the rat insulin-secreting cell line CRI-G1.

Authors:  P S Herson; M L Ashford
Journal:  J Physiol       Date:  1997-05-15       Impact factor: 5.182

5.  Preventing insulin dependent diabetes mellitus.

Authors:  K G Alberti
Journal:  BMJ       Date:  1993-12-04

Review 6.  New concepts in diabetes mellitus. I: Treatment, pregnancy and aetiology.

Authors:  R Taylor; M Vanderpump
Journal:  Postgrad Med J       Date:  1994-06       Impact factor: 2.401

Review 7.  Prevention strategies for type 1 diabetes.

Authors:  Christopher M Kishiyama; H Peter Chase; Jennifer M Barker
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

8.  Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study).

Authors:  P Pozzilli; N Visalli; A Signore; M G Baroni; R Buzzetti; M G Cavallo; M L Boccuni; D Fava; C Gragnoli; D Andreani
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

9.  Comparative study of the binding characteristics to and inhibitory potencies towards PARP and in vivo antidiabetogenic potencies of taurine, 3-aminobenzamide and nicotinamide.

Authors:  Kashyap G Pandya; Maulik R Patel; Cesar A Lau-Cam
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

10.  Properties of Flavonoids Isolated from the Bark of Eysenhardtia polystachya and Their Effect on Oxidative Stress in Streptozotocin-Induced Diabetes Mellitus in Mice.

Authors:  Rosa Martha Perez-Gutierrez; Abraham Heriberto Garcia-Campoy; Alethia Muñiz-Ramirez
Journal:  Oxid Med Cell Longev       Date:  2016-09-07       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.